… buprenorphine/naloxone inductions of four individuals who tested positive for fentanyl. …
OUD individuals onto buprenorphine/naloxone maintenance, 16, 17 and our use of the …

… of care, with buprenorphine/naloxone generally offered for … study were to assess the impact
of fentanyl use on (1) MOUD … initiating methadone or buprenorphine/naloxone as part of a …

… on non-prescribed buprenorphine use among individuals with opioid use disorder. Qualitative
… I would need Suboxone (buprenorphine and naloxone) to get well in order to function. …

… Six studies have also demonstrated the use of transdermal fentanyl or buprenorphine
patches as viable bridging treatments to eliminate withdrawal symptoms during the transition to …

… buprenorphine vs sublingual buprenorphine-naloxone, stratified into subgroups, who (1)
exhibited evidence of fentanyl use … results for fentanyl or norfentanyl (ie, fentanyl positive), or (2) …

… Although buprenorphine/naloxone (BUP/NX) is an evidence-based, first-line opioid agonist
… pharmacokinetics of illicit fentanyl use, one animal model did show that multiple boluses of …

… transdermal fentanyl as a bridge between methadone to buprenorphine/naloxone induction
… To our knowledge, this method of bridging using fentanyl has not been described previously …

… This case series aims to describe micro-dosing to initiate buprenorphine/naloxone in a
fentanyl exposed population in an outpatient setting. We describe both patients on OAT, either …

… and fentanyl exposure were correlated with lifetime use of diverted buprenorphine/naloxone,
but none correlated with use of diverted buprenorphine/naloxone in the past 2 months. …

… formulations indicated for OUD treatment (ie, sublingual buprenorphine/naloxone film or
tablets and buprenorphine monoproducts). Products specifically FDA-approved for pain …